References
- Hahn BH. Systemic lupus erythematosus. In: Fauci AS, Langford CA, editors. Harrison's rheumatology. 3rd ed. New York: McGraw-Hill; 2013. p. 68-83.
- Choi JJ. Current clinical practice: Diagnosis and treatment of systemic lupus erythematosus. The Korean Journal of Medicine. 2010;78(4):437-443.
- Alsowaida N, Alrasheed M, Mayet A, Alsuwaida A, Omair MA. Medication adherence, depression and disease activity among patients with systemic lupus erythematosus. Lupus. 2018;27(2):327-332. https://doi.org/10.1177/0961203317725585
- Marengo MF, Waimann CA, de Achaval S, Zhang H, Garcia-Gonzalez A, Richardson MN, et al. Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring. Lupus. 2012;21(11):1158-1165. https://doi.org/10.1177/0961203312447868
- Julian LJ, Yelin E, Yazdany J, Panopalis P, Trupin L, Criswell LA, et al. Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis Care & Research. 2009;61(2):240-246. https://doi.org/10.1002/art.24236
- Kozora E, Ellison MC, Waxmonsky JA, Wamboldt FS, Patterson TL. Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus. Lupus. 2005;14(5):363-372. https://doi.org/10.1191/0961203305lu2094oa
- Howard P. December's topic of the month-coping with depression and anxiety [Internet]. Romford: Lupus UK; 2017 [cited 2019 January 15]. Available from: https://www.lupusuk.org.uk/coping-with-depression-andanxiety.
- Park JW, Kim DH, Suh YS, Kim JB, Lee GH. Drug compliance according to severity of depressive symptoms in medically ill outpatients. Korean Journal of Health Promotion. 2007;7(1):39-44.
- DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine. 2000;160(14):2101-2107. https://doi.org/10.1001/archinte.160.14.2101
- Duvdevany I, Cohen M, Minsker-Valtzer A, Lorber M. Psychological correlates of adherence to self-care, disease activity and functioning in persons with systemic lupus erythematosus. Lupus. 2011;20(1):14-22. https://doi.org/10.1177/0961203310378667
- Mosley-Williams A, Lumley MA, Gillis M, Leisen J, Guice D. Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Care & Research. 2002;47(6):630-638. https://doi.org/10.1002/art.10790
- Bandura A. Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review. 1977;84(2):191-215. https://doi.org/10.1037/0033-295X.84.2.191
- Chao J, Nau DP, Aikens JE, Taylor SD. The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. Research in Social and Administrative Pharmacy. 2005;1(4):508-525. https://doi.org/10.1016/j.sapharm.2005.09.002
- Hilliard ME, Eakin MN, Borrelli B, Green A, Riekert KA. Medication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis. Health Psychology. 2015; 34(5):496-504. https://doi.org/10.1037/hea0000136
- Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research. 1999;47(6):555-567. https://doi.org/10.1016/S0022-3999(99)00057-4
- Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1(3):385-401. https://doi.org/10.1177/014662167700100306
- Chon KK, Choi SC, Yang BC. Integrated adaptation of CES-D in Korea. Korean Journal of Health Psychology. 2001;6(1):59-76.
- Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B, Rogers RW. The self-efficacy scale: Construction and validation. Psychological Reports. 1982;51(2):663-671. https://doi.org/10.2466/pr0.1982.51.2.663
- Oh PJ. A model for health promoting behaviors and quality of life in people with stomach cancer [dissertation]. Seoul: Seoul National University; 1994. p. 1-164.
- Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health. 1999;14(1):1-24. https://doi.org/10.1080/08870449908407311
- Kim Y, Min YH. Validity and reliability of the Korean version of the Beliefs about Medicines Questionnaire: Specific for breast cancer patients on hormone therapy. Journal of Health Informatics and Statistics. 2017;42(2):136-143. https://doi.org/10.21032/jhis.2017.42.2.136
- de Klerk E, van der Heijde D, van der Tempel H, van der Linden S. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. The Journal of Rheumatology. 1999;26(12):2635-2641.
- de Klerk E, van der Heijde D, Landewe R, van der Tempel H, van der Linden S. The Compliance-Questionnaire-Rheumatology compared with electronic medication event monitoring: A validation study. The Journal of Rheumatology. 2003;30(11):2469-2475.
- Lee JY, Lee SY, Hahn HJ, Son IJ, Hahn SG, Lee EB. Cultural adaptation of a compliance questionnaire for patients with rheumatoid arthritis to a Korean version. The Korean Journal of Internal Medicine. 2011;26(1):28-33. https://doi.org/10.3904/kjim.2011.26.1.28
- Hayes AF. Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. Lee HK, translator. Seoul: Shinyoungsa; c2015. p. 112-144.
- Kim GG. Predictors of medication adherence in ischemic stroke survivors [master's thesis]. Gwangju: Chonnam National University;2017. p. 1-73.
- Sohng KY. The effects of a self-management course on self-efficacy, fatigue, coping skills and self-care activities in patients with systemic lupus erythematosus. Journal of Muscle and Joint Health. 2001;8(2):346-356.
- Sohng KY, Paik SI, Cho OH. An analysis of health counselling by the internet in one lupus center. The Journal of Rheumatology Health. 2004;11(1):42-49.